John Schiller, National Cancer Institute, Bethesda
The human papilloma virus vaccine, which is currently being tested in the prevention of cervical cancer, brings together both infectious disease and cancer. Delegates at the ICAAC conference heard an update on both the anti-cancer and the anti-wart activities of the two vaccines: one from Merck and the other from GlaxoSmithKline.
Reporting from:
ECCO-13 The European Cancer Conference, Paris, October 30–November 3, 2005
In this edition:
Martine Piccart gave the Paris ECCO conference her
Reporting from:
- European Society for Medical Oncology Congress, October 29-November 10, 2004, Vienna
- Journal of Clinical Oncology
- New England Journal
Post a comment